Vaccination versus SARS-CoV-2 Omicron:three vaccine doses win the battle  

作　　者：Grzegorz Maria Popowicz Krzysztof Pyrc Kamyar Hadian 

机构地区：[1]Helmholtz Zentrum München,German Research Center for Environmental Health(GmbH),Institute of Structural Biology,Ingolstädter Landstrasse 1,85764,Neuherberg,Germany [2]Virogenetics Laboratory of Virology,Malopolska Centre of Biotechnology,Jagiellonian University,Gronostajowa 7a,30-387,Krakow,Poland [3]Helmholtz Zentrum München,German Research Center for Environmental Health(GmbH),Research Group Cell Signaling and Chemical Biology,Institute of Molecular Toxicology and Pharmacology,Ingolstädter Landstrasse 1,85764,Neuherberg,Germany

出　　处：《Signal Transduction and Targeted Therapy》2022年第5期1373-1374,共2页信号转导与靶向治疗（英文）

基　　金：This work is supported by the Bayerische Forschungsstiftung grant AZ-1453-20C(to G.M.P.);the Deutsche Forschungsgemeinschaft,grants PO 1851/4-1(to G.P.);subsidy from the Polish Ministry of Science and Higher Education for research on SARS-CoV-2 and a grant from the National Science Center(UMO-2017/27/B/NZ6/02488)and by EU-Horizon2020 ITN OrganoVir grant 812673(to K.P).Open Access funding enabled and organized by Project DEAL.

摘　　要：The here highlighted study by Garcia-Beltran et al.demonstrates that SARS-CoV-2 Omicron can largely escape the immune responses.Hence,while two doses of COVID-19 vaccines seem to be insufficient to provide protection against Omicron,a third dose provides mature neutralizing antibodies to enhance the response.1 Since March 2020,when the World Health Organization(WHO;www.who.int)officially declared the COVID-19 pandemic caused by the SARS-CoV-2.

关 键 词：doses NEUTRAL OMI 

分 类 号：R186[医药卫生—流行病学] R563.1[医药卫生—公共卫生与预防医学]